ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis

U. Darsow, A. Wollenberg, D. Simon, A. Taïeb, T. Werfel, A. Oranje, C. Gelmetti, A. Svensson, M. Deleuran, A. M. Calza, F. Giusti, J. Lübbe, S. Seidenari, J. Ring

Research output: Contribution to journalArticle

228 Citations (Scopus)

Abstract

Background The diagnosis of atopic dermatitis (AD) is made using evaluated clinical criteria. Management of AD must consider the symptomatic variability of the disease. Methods EADV eczema task force developed its guideline for atopic dermatitis diagnosis and treatment based on literature review and repeated consenting group discussions. Results and Discussion Basic therapy relies on hydrating topical treatment and avoidance of specific and unspecific provocation factors. Anti-inflammatory treatment based on topical glucocorticosteroids and topical calcineurin antagonists is used for exacerbation management and more recently for proactive therapy in selected cases. Topical corticosteroids remain the mainstay of therapy, but the topical calcineurin inhibitors, tacrolimus and pimecrolimus are preferred in certain locations. Systemic anti-inflammatory treatment is an option for severe refractory cases. Microbial colonization and superinfection may induce disease exacerbation and can justify additional antimicrobial/antiseptic treatment. Systemic antihistamines (H1) can relieve pruritus, but do not have sufficient effect on eczema. Adjuvant therapy includes UV irradiation preferably of UVA1 wavelength or UVB 311 nm. Dietary recommendations should be specific and given only in diagnosed individual food allergy. Allergen-specific immunotherapy to aeroallergens may be useful in selected cases. Stress-induced exacerbations may make psychosomatic counselling recommendable. 'Eczema school' educational programmes have been proven to be helpful.

Original languageEnglish
Pages (from-to)317-328
Number of pages12
JournalJournal of the European Academy of Dermatology and Venereology
Volume24
Issue number3
DOIs
Publication statusPublished - 2010

Fingerprint

Eczema
Advisory Committees
Atopic Dermatitis
Therapeutics
Anti-Inflammatory Agents
Immunologic Desensitization
Superinfection
Local Anti-Infective Agents
Food Hypersensitivity
Histamine Antagonists
Tacrolimus
Pruritus
Disease Progression
Counseling
Adrenal Cortex Hormones
Guidelines

Keywords

  • Atopic dermatitis
  • Eczema
  • Guideline
  • Therapy

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases
  • Medicine(all)

Cite this

ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. / Darsow, U.; Wollenberg, A.; Simon, D.; Taïeb, A.; Werfel, T.; Oranje, A.; Gelmetti, C.; Svensson, A.; Deleuran, M.; Calza, A. M.; Giusti, F.; Lübbe, J.; Seidenari, S.; Ring, J.

In: Journal of the European Academy of Dermatology and Venereology, Vol. 24, No. 3, 2010, p. 317-328.

Research output: Contribution to journalArticle

Darsow, U, Wollenberg, A, Simon, D, Taïeb, A, Werfel, T, Oranje, A, Gelmetti, C, Svensson, A, Deleuran, M, Calza, AM, Giusti, F, Lübbe, J, Seidenari, S & Ring, J 2010, 'ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis', Journal of the European Academy of Dermatology and Venereology, vol. 24, no. 3, pp. 317-328. https://doi.org/10.1111/j.1468-3083.2009.03415.x
Darsow, U. ; Wollenberg, A. ; Simon, D. ; Taïeb, A. ; Werfel, T. ; Oranje, A. ; Gelmetti, C. ; Svensson, A. ; Deleuran, M. ; Calza, A. M. ; Giusti, F. ; Lübbe, J. ; Seidenari, S. ; Ring, J. / ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. In: Journal of the European Academy of Dermatology and Venereology. 2010 ; Vol. 24, No. 3. pp. 317-328.
@article{d360526e046f45b09edf9e6c3b4ac111,
title = "ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis",
abstract = "Background The diagnosis of atopic dermatitis (AD) is made using evaluated clinical criteria. Management of AD must consider the symptomatic variability of the disease. Methods EADV eczema task force developed its guideline for atopic dermatitis diagnosis and treatment based on literature review and repeated consenting group discussions. Results and Discussion Basic therapy relies on hydrating topical treatment and avoidance of specific and unspecific provocation factors. Anti-inflammatory treatment based on topical glucocorticosteroids and topical calcineurin antagonists is used for exacerbation management and more recently for proactive therapy in selected cases. Topical corticosteroids remain the mainstay of therapy, but the topical calcineurin inhibitors, tacrolimus and pimecrolimus are preferred in certain locations. Systemic anti-inflammatory treatment is an option for severe refractory cases. Microbial colonization and superinfection may induce disease exacerbation and can justify additional antimicrobial/antiseptic treatment. Systemic antihistamines (H1) can relieve pruritus, but do not have sufficient effect on eczema. Adjuvant therapy includes UV irradiation preferably of UVA1 wavelength or UVB 311 nm. Dietary recommendations should be specific and given only in diagnosed individual food allergy. Allergen-specific immunotherapy to aeroallergens may be useful in selected cases. Stress-induced exacerbations may make psychosomatic counselling recommendable. 'Eczema school' educational programmes have been proven to be helpful.",
keywords = "Atopic dermatitis, Eczema, Guideline, Therapy",
author = "U. Darsow and A. Wollenberg and D. Simon and A. Ta{\"i}eb and T. Werfel and A. Oranje and C. Gelmetti and A. Svensson and M. Deleuran and Calza, {A. M.} and F. Giusti and J. L{\"u}bbe and S. Seidenari and J. Ring",
year = "2010",
doi = "10.1111/j.1468-3083.2009.03415.x",
language = "English",
volume = "24",
pages = "317--328",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "wiley",
number = "3",

}

TY - JOUR

T1 - ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis

AU - Darsow, U.

AU - Wollenberg, A.

AU - Simon, D.

AU - Taïeb, A.

AU - Werfel, T.

AU - Oranje, A.

AU - Gelmetti, C.

AU - Svensson, A.

AU - Deleuran, M.

AU - Calza, A. M.

AU - Giusti, F.

AU - Lübbe, J.

AU - Seidenari, S.

AU - Ring, J.

PY - 2010

Y1 - 2010

N2 - Background The diagnosis of atopic dermatitis (AD) is made using evaluated clinical criteria. Management of AD must consider the symptomatic variability of the disease. Methods EADV eczema task force developed its guideline for atopic dermatitis diagnosis and treatment based on literature review and repeated consenting group discussions. Results and Discussion Basic therapy relies on hydrating topical treatment and avoidance of specific and unspecific provocation factors. Anti-inflammatory treatment based on topical glucocorticosteroids and topical calcineurin antagonists is used for exacerbation management and more recently for proactive therapy in selected cases. Topical corticosteroids remain the mainstay of therapy, but the topical calcineurin inhibitors, tacrolimus and pimecrolimus are preferred in certain locations. Systemic anti-inflammatory treatment is an option for severe refractory cases. Microbial colonization and superinfection may induce disease exacerbation and can justify additional antimicrobial/antiseptic treatment. Systemic antihistamines (H1) can relieve pruritus, but do not have sufficient effect on eczema. Adjuvant therapy includes UV irradiation preferably of UVA1 wavelength or UVB 311 nm. Dietary recommendations should be specific and given only in diagnosed individual food allergy. Allergen-specific immunotherapy to aeroallergens may be useful in selected cases. Stress-induced exacerbations may make psychosomatic counselling recommendable. 'Eczema school' educational programmes have been proven to be helpful.

AB - Background The diagnosis of atopic dermatitis (AD) is made using evaluated clinical criteria. Management of AD must consider the symptomatic variability of the disease. Methods EADV eczema task force developed its guideline for atopic dermatitis diagnosis and treatment based on literature review and repeated consenting group discussions. Results and Discussion Basic therapy relies on hydrating topical treatment and avoidance of specific and unspecific provocation factors. Anti-inflammatory treatment based on topical glucocorticosteroids and topical calcineurin antagonists is used for exacerbation management and more recently for proactive therapy in selected cases. Topical corticosteroids remain the mainstay of therapy, but the topical calcineurin inhibitors, tacrolimus and pimecrolimus are preferred in certain locations. Systemic anti-inflammatory treatment is an option for severe refractory cases. Microbial colonization and superinfection may induce disease exacerbation and can justify additional antimicrobial/antiseptic treatment. Systemic antihistamines (H1) can relieve pruritus, but do not have sufficient effect on eczema. Adjuvant therapy includes UV irradiation preferably of UVA1 wavelength or UVB 311 nm. Dietary recommendations should be specific and given only in diagnosed individual food allergy. Allergen-specific immunotherapy to aeroallergens may be useful in selected cases. Stress-induced exacerbations may make psychosomatic counselling recommendable. 'Eczema school' educational programmes have been proven to be helpful.

KW - Atopic dermatitis

KW - Eczema

KW - Guideline

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=76349105505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76349105505&partnerID=8YFLogxK

U2 - 10.1111/j.1468-3083.2009.03415.x

DO - 10.1111/j.1468-3083.2009.03415.x

M3 - Article

C2 - 19732254

AN - SCOPUS:76349105505

VL - 24

SP - 317

EP - 328

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

IS - 3

ER -